New-onset conduction disturbances still represent a considerable problem after transcatheter aortic valve implantation (TAVI). The aim of this study was to identify calcification patterns with an elevated risk for permanent pacemaker implantation (PPI) after TAVI and investigate underlying mechanisms in an ex vivo setting.
Introduction
For patients with severe symptomatic aortic stenosis, surgical aortic valve replacement (SAVR) has been the standard of care for decades. In recent years, transcatheter aortic valve implantation (TAVI) has established itself as a less invasive alternative for patients with a prohibitive surgical risk. 1, 2 Due to the favourable outcomes achieved, the expansion of the indication for TAVI is the subject of current debate. 3 Compared with SAVR, certain complications are observed more frequently during TAVI which are of potential concern regarding long-term outcomes. According to a recent meta-analysis, new-onset conduction disturbances (NOCD) represent the most frequent adverse event. 4 The clinical consequences associated with NOCD are being controversially discussed in the current literature. 5 -8 Numerous risk factors for the occurrence of AVB and the need of permanent pacemaker implantation (PPI) have been suggested, such as pre-existing right bundle branch block (RBBB), height of implantation, or the type of transcatheter heart valve (THV) implanted. 9 -11 However, despite advances in THV design and modification of implantation techniques, the rates of NOCD after TAVI remain undesirably high. 12 An important anatomical factor that has not been investigated in the past is asymmetric calcification patterns of the aortic valve. Asymmetric calcification patterns may lead to an uneven distribution of radial forces exerted on the aortic annulus and its adjacent structures. Some calcification patterns therefore might promote injury of conduction pathways which are located between and under the non-and right coronary cusp (RCC). Accordingly, the aim of this study was to identify calcification patterns with an elevated risk for the occurrence of conduction abnormalities and investigate underlying mechanisms in an ex vivo setting.
Methods

Study population
Three hundred and thirty-four consecutive patients who underwent elective TAVI between July 2012 and December 2013 at our institution were identified. Patients were excluded from this analysis if patients were treated with a THV other than the Edwards SAPIEN XT w or Medtronic CoreValve w (n ¼ 40), image quality of pre-operative cardiac multi slice computed tomography (MSCT) did not seem sufficient (n ¼ 100) or PPI had been performed before (n ¼ 32). The final study population therefore comprised 162 patients. The primary endpoint of this study was PPI. Procedural outcomes were analysed according to the Valve Academic Research Consortium (VARC)-2 criteria. 13 PPI was performed according to current European guidelines for cardiac pacing and resynchronization therapy. 14 
Quantification of the calcium load
In a first step, the calcium load of the aortic valve cusps and the left ventricular outflow tract (LVOT) was quantified with 3mensio w Medical
Imaging (Bilthoven, the Netherlands) based on pre-operative MSCT images. Electrocardiography (ECG)-triggered cardiac MSCT was acquired with the Biograph mCT 128 (Siemens Healthcare, Siemens AG, Erlangen, Germany) during an RR interval of 60 -70%. In total, 60 -70 mL of iomeprol was administered intravenously and the slice thickness set at 0.6 mm. The window of interest for calcium quantification was defined as follows: for the aortic valve cusps, the area of interest reached from the basal plane to the origin of the lower coronary artery or 15 mm above the basal plane (whatever was nearer to the basal plane). The window for the LVOT comprised the volume expanding from the basal plane to 10 mm below the basal plane. Every voxel above the predefined threshold of 500 Hounsefield units (HU) was counted as 'calcium'. If this threshold was not appropriate to adequately capture the calcium, the threshold was manually adjusted. 15 All voxels exceeding the threshold were summed up to calculate the calcium volume ( Figure 1 ).
To assess each cusp separately, 3mensio w offers a mask in the shape of a three-pointed 'Mercedes' star with adjustable arms to adapt to individual patient anatomy ( Figure 1B) . The acquired data were analysed for possible relationships between the calcium load of the valve cusps and LVOT and the need for PPI. Based on these results, two representative patients were chosen for an ex vivo simulation, one with an elevated risk for PPI who actually underwent PPI and one with a low risk who did not require PPI. Patients with known patient-or procedure-related risk factors (RBBB, excessive oversizing, postdilation) were excluded for the simulation.
Assessment of balloon deployment in a 3D model
Next, the aortic annuli including the calcified cusps of these two patients were 3D printed using data from respective MSCT images. Using Mimics TM (Materialise, Leuven, Belgium), MSCT datasets were analysed and segmented to create 3D models of the LVOT and calcification volumes. The models were post-processed using 3Matic TM (Materialise) to create files suitable for 3D printing and moulding of mock aortic root vessels with calcified leaflets (Figure 2 ). Three stereolithography (STL) files were designed: an aortic root wall, a calcium volume piece with a holder for placing and connecting different segments, andleaflet base. The files were printed using an Objet Eden 350 (Objet, Rehovot, Israel) with Fullcure w material. The aortic root wall was printed with thin walls to allow for breaking and removal from the silicone form after casting. Figure 1 Calcium quantification with the 3mensio w Medical Imaging. For the aortic valve, the window of interest was defined as the area from the basal plane to 15 mm above this plane or the origin of the lower coronary artery (A). With help of the adjustable 'Mercedes' star, the calcium load of the three cusps was assessed separately (B).
The calcium piece was connected to a ring holder with arrows indicating the positions of the coronaries to ensure proper radial alignment during creation of the silicone model. The calcium piece was dyed red for better visualization ( Figure 2) . Next, the aortic root wall was placed inside a Plexiglas tube with an inner diameter of 50 mm. Silicone was cast into the space between the outside of the aortic root wall and the Plexiglas tube to create a negative form of the aortic blood volume. The aortic wall piece was then removed. The leaflet base was subsequently placed into the bottom of the model and the calcium piece inserted from the top and aligned. A thin film of silicone representing the leaflets was then cast from the top to connect the calcium to the leaflets. The model was rotated during curing to ensure good silicone distribution. Once the silicone had cured, the leaflet base and holder ring of the calcium piece were removed, leaving a silicone aortic root model with leaflets and calcifications ( Figure 2) . The calcifications were thus the only remaining solid 3D-printed pieces, reflecting the nature of aortic valve calcifications. Finally, the model was placed in a holder and a delivery catheter inserted within the valve model. Balloon valvuloplasty (BAV) and THV implantation were performed to analyse the direction and amount of device deflection. The balloon types and sizes corresponded to the exact same balloons that were actually used for the respective patient procedures. Balloons were inflated according to the manufacturer's recommendations. Videos and still images were acquired during the procedure.
Statistical analysis
Normally distributed variables are expressed as mean + standard deviation. For non-normally distributed variables, the median and inter-quartile range (IQR) were calculated and tested for statistical significance with the Mann-Whitney U test. To identify the best discriminatory threshold of the calcium volume for PPI, the Youden Index was determined for the total calcium volume of the aortic annulus, for each cusp separately and LVOT. To investigate the independent influence of possible factors on PPI, a multiple binary logistic regression analysis was performed. First, a univariate regression analysis was performed for the following variables: age, gender, body mass index (BMI), left ventricular ejection fraction (LVEF), coronary artery disease (CAD), previous myocardial infarction (MI), previous cardiac surgery, hypertension, diabetes mellitus, chronic obstructive pulmonary disease (COPD), carotid artery stenosis, pulmonary hypertension, heart rhythm, heart rate, PQ interval, QRS duration, atrioventricular block (AVB), pre-existing RBBB, preexisting left bundle branch block (LBBB), calcium volume above highest Youden Index for each aortic valve cusp, the sum of the three cusps and LVOT, THV device, post-dilations, degree of oversizing, and depth of THV implantation. Variables with a P-value of ,0.05 were included into the multivariate regression model to test for independent associations. All statistical analyses were performed with IBM SPSS Statistics, Version 22.0 (IBM Corp., Armonk, NY, USA). 
Calcium load and pacemaker implantation
The study was approved by the local institutional review board and is in accordance with the Declaration of Helsinki. All patients gave written informed consent.
Results
Patient cohort
Baseline characteristics of the study population are summarized in Table 1 . 59.3% of patients was female, the mean age 82 + 5 years, and ejection fraction 51 + 10%. 12.3% presented with pre-existing RBBB. 61.1% were treated with the Edwards SAPIEN XT w and the remaining 39.9% received a Medtronic CoreValve w ( Table 1) . PPI was performed in 9.9% after a median time of 6 days (IQR 2-7) after the procedure. In 93.8%, PPI was performed due to complete AVB ( Table 2) .
Left coronary cusp calcification correlated with PPI
Calcium quantification of the aortic valve, its three cusps, and the LVOT is presented in Tables Table 4) . Likewise, all other variables were not predictive ( Table 4) .
Ex vivo simulation showed peripheral shift of the balloon and THV in asymmetrically calcified annulus
Simulations of BAV and THV deployment in an aortic annulus matching the above risk profile with an elevated LCC calcium amount and in a control annulus with a low risk were performed and are depicted in Figure 2 . Detailed information about the respective patients who served as templates for the simulation are presented in Table 5 . In the aortic annulus with an elevated LCC calcium load, the fully deployed THV (both SAPIEN XT w and CoreValve Evolut w ) and the balloon clearly shifted away from LCC towards the commissure between RCC and NCC ( Figure 2A , red arrows). BAV and THV deployment into an annulus with a fairly symmetrical calcium distribution showed no significant balloon shift off the centerline ( Figure 2B ). Figure 3 ).
Discussion
In this study, we analysed the impact of aortic valve calcium distribution on the occurrence of AVB requiring PPI after TAVI. Two major findings can be drawn from this study: (i) an elevated calcium load in the LCC and pre-existing RBBB emerged as independent risk factors for PPI after TAVI and (ii) combination of these two factors enabled us to discriminate between patients with differing risk for PPI after TAVI. Numerous risk factors for PPI after TAVI have been suggested throughout recent years but only pre-existing RBBB, implantation of a CoreValve w , and a low implantation position of the THV were consistently shown by independent investigators to be associated with PPI after TAVI. 16 -18 Some studies investigated the association between the quantitative calcium burden of the aortic annulus and the need for PPI, 19 -21 but results are not convincing.
Some authors could not demonstrate a relationship between the quantitative calcium burden of the aortic annulus and new-onset conduction disorders. 19, 20 In contrast, Latsios et al. 21 could show an elevated risk for PPI with increasing calcification of the CoreValve w landing zone and concluded that calcium accumulation near the conduction pathways leads to disruption of AV conduction. However, this study only analysed 81 patients and was not sufficiently powered. In addition, the calcium load was quantified according to the semi-quantitative Agatston score, which was originally introduced to quantify coronary calcification and categorizes the degree of calcification into four levels not allowing for a detailed and accurate assessment of the calcium distribution. 21, 22 Data of the current study revealed that the total calcium burden of the aortic valve was not related to PPI, but a strong correlation between an elevated level of LCC calcification and PPI was found. To shed more light into possible underlying mechanisms, we decided to simulate TAVI procedures of real patients by printing 3D-silicone aortic annuli and perform BAV and THV deployment with one balloon and one self-expandable THV. As described above, two patients treated with a SAPIEN XT w valve served as templates for this simulation. Interestingly, this experiment demonstrated a clear shift of the valvuloplasty balloon and the respective THV away from the LCC towards the RCC/NCC region harbouring the conduction pathways (Figure 2A) . This balloon and THV shift off centreline was not seen in our control annulus representing a low pacemaker risk constellation ( Figure 2B) . At this stage, we speculate that a localized elevated radial force directly applied on the conduction pathways within the annular wall as a consequence of a decentralized BAV or an off-centreline placement of the THV may have caused this lesion.
The observed increased LCC calcification was not related to new-onset LBBB which was surprising as the left bundle branch is also localized within the annular wall between RCC and NCC. At this point, it is important to look at potential mechanisms leading to complete AVB after TAVI. Pre-existing RBBB was shown to be the most powerful predictor by numerous investigators, 9, 17, 18 and new-onset LBBB is the most frequent complication observed after a TAVI procedure. 4, 12 Based on these observations, van der Boon et al. 12 speculated that complete AVB may be the result of newonset LBBB in patients with pre-existing RBBB or complete interruption of AV conduction in patients with or without pre-existing conduction disturbances. As a consequence, patients with preexisting RBBB, who suffer from new LBBB, cannot be distinguished from patients with pre-existing RBBB, who suffer from complete AV block. Therefore, patients with pre-existing RBBB sustaining new Figure 3 The risk for PPI according to the presence or absence of the two identified risk factors is depicted. In patients who had both, preexisting RBBB, and an elevated LCC calcium burden, the risk for PPI was 53.8%, whereas in patients who had neither pre-existing RBBB nor an elevated LCC calcium load, had a 1.4% chance to require PPI. If one of the two risk factors was present, the risk for PPI did not largely differ from the overall risk of 9.9%.
LBBB cannot be identified and taken into account for the statistical analysis. This limitation may explain the lacking relationship between LCC calcification and new-onset LBBB. Utilizing the two identified risk factors, we identified a group of patients who were at very low risk for PPI (1.4%) for the analysed two devices which lies within the range of AVB after SAVR 23 ( Figure 3) . This finding has important clinical implications in particular with regard to the growing debate on whether the indication for TAVI should be extended to patients exposed to an intermediate surgical risk. It is of utmost importance to discriminate patients according to their risk for adverse events affecting long-term prognosis after TAVI, such as PPI. Long-term permanent pacing has been shown to induce dyssynchronous activation of the ventricles and worsen cardiac output and might be associated with impaired longterm outcomes. 24 Very recent studies showed an increased risk for death in patients requiring PPI after TAVI compared with those not requiring permanent pacing. 25 Therefore, insights of this study may be helpful by providing additional information to address potential risk factors such as PPI and help to identify appropriate patients in this subset. Finally, we think that a combined approach of clinical data analysis and ex vivo simulation of certain aspects of the patient anatomy and procedural steps is a promising approach to identify risks and understand their underlying mechanisms. This will help to find additional refined parameters for patient and prosthesis selection to optimize procedural success, minimize adverse events, and maximize patient safety. This study has several limitations. First, it was a retrospective analysis with its known limitations. Second, we applied a fairly new calcium quantification algorithm which has not been validated before in terms of inter-observer and inter-institutional variability. Third, all investigated patients underwent MSCT with iodine administration which resulted in a threshold for detection of calcification of 500 HU. However, no native MSCT images were investigated in our study, and therefore, our study protocol may need to be validated for native MSCT images. Finally, although modern 3D printing technology and the choice of material for our custom made silicone model made it as realistic as possible, some experimental designdependent simplifications had to be accepted, and therefore, the THV -calcium interaction of this model might not reflect the entire complexity of actual in vivo conditions.
In conclusion, we identified an elevated LCC calcium load and confirmed pre-existing RBBB as independent predictors for PPI after TAVI. The combination of these two factors allowed us to distinguish between patients who are at increased risk for postprocedural PPI and those who are not. In addition, we could demonstrate an off-centreline deployment of the balloon and THV due to this calcification pattern as a potential underlying mechanism for our observation. 
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